Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors.

To identify novel non-nucleoside DNA methyltransferase (DNMT) inhibitors, we designed and synthesized a series of maleimide derivatives. Among this series, compounds 5-8 were found to be more potent DNMT1 inhibitors than RG108, a DNMT1 inhibitor reported previously by Siedlecki et al. The binding mode analysis of compound 5 is also reported.

[1]  David A Jones,et al.  Reactivating the expression of methylation silenced genes in human cancer , 2002, Oncogene.

[2]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[3]  Frank Lyko,et al.  Discovery of two novel, small-molecule inhibitors of DNA methylation. , 2006, Journal of medicinal chemistry.

[4]  R. Roberts,et al.  Enzymatic C5-cytosine methylation of DNA: mechanistic implications of new crystal structures for HhaL methyltransferase-DNA-AdoHcy complexes. , 1996, Journal of molecular biology.

[5]  Rudolf Jaenisch,et al.  Role for DNA methylation in genomic imprinting , 1993, Nature.

[6]  R J Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 1999, The Journal of Biological Chemistry.

[7]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[8]  M. Esteller CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[9]  William Arbuthnot Sir Lane,et al.  Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. , 1991, Biochemistry.

[10]  Esteban Ballestar,et al.  The impact of chromatin in human cancer: linking DNA methylation to gene silencing. , 2002, Carcinogenesis.

[11]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[12]  Ming-Rong Wang,et al.  Anticancer drug discovery targeting DNA hypermethylation. , 2008, Current medicinal chemistry.

[13]  D. Santi,et al.  Kinetic and catalytic mechanism of HhaI methyltransferase. , 1987, The Journal of biological chemistry.

[14]  V. Ingram,et al.  Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. , 1988, Journal of molecular biology.

[15]  T. Bestor,et al.  A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. , 1998, Human molecular genetics.

[16]  Nadine H. Elowe,et al.  Constrained (l-)-S-adenosyl-l-homocysteine (SAH) analogues as DNA methyltransferase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[17]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[18]  F. Lyko,et al.  DNA Methyltransferase Inhibitors for Cancer Therapy , 2007, Cancer journal.

[19]  Takayoshi Suzuki,et al.  Epigenetic control using natural products and synthetic molecules. , 2006, Current medicinal chemistry.

[20]  D. Hornby,et al.  Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. , 2002, Journal of Molecular Biology.

[21]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[22]  A. Surolia,et al.  Activation and inhibition of DNA methyltransferases by S-adenosyl-L-homocysteine analogues. , 2008, Bioorganic & medicinal chemistry.

[23]  Nadine H. Elowe,et al.  SAR around (l)-S-adenosyl-l-homocysteine, an inhibitor of human DNA methyltransferase (DNMT) enzymes. , 2009, Bioorganic & medicinal chemistry letters.

[24]  M. Lübbert,et al.  DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. , 2000, Current topics in microbiology and immunology.

[25]  J. Kirk Gene silencing. , 2004, New England Journal of Medicine.

[26]  E. Novellino,et al.  Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1. , 2008, Journal of medicinal chemistry.